Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001802653-23-000002
Filing Date
2023-08-21
Accepted
2023-08-21 17:07:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2847
  Complete submission text file 0001802653-23-000002.txt   4239
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Subject) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-34186 | Film No.: 231189915
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON, DC DC 20037
Business Address
Wijkstrom Joakim (Reporting) CIK: 0001785888 (see all company filings)

Type: 144